Heffner J E
Department of Medicine, Medical University of South Carolina, Charleston 29425, USA.
Semin Respir Infect. 1999 Mar;14(1):48-58.
A patient with pneumonia who develops a parapneumonic effusion challenges the physician to determine the need for pleural fluid drainage. This determination is influenced by multiple factors including the patient's general state of health, the existence of comorbidities, the virulence of the underlying pathogen, and the extent of the pneumonia that dictate clinical outcome and the relative risks and benefits of drainage. The presence of intrapleural pus represents the only factor that clearly establishes the need for drainage, although most experts recommend draining pleural fluid that is positive by Gram's stain or culture for a pathogen. Other factors such as the extent of the patient's pneumonia, severity of systemic signs of inflammation, radiographic features of the effusion, and pleural fluid chemical profile assist clinical decision making. The fundamental principle that guides therapy is the need to promptly and effectively drain pleural fluid whenever it appears likely that it will progress to a frank empyema with antibiotic therapy alone.
患有肺炎并出现类肺炎性胸腔积液的患者,对医生判断是否需要进行胸腔积液引流提出了挑战。这一判断受多种因素影响,包括患者的总体健康状况、合并症的存在、潜在病原体的毒力以及肺炎的范围,这些因素决定了临床结局以及引流的相对风险和益处。胸腔内存在脓液是明确表明需要引流的唯一因素,不过大多数专家建议,对于革兰氏染色或病原体培养呈阳性的胸腔积液应进行引流。其他因素,如患者肺炎的范围、全身炎症体征的严重程度、胸腔积液的影像学特征以及胸腔积液的化学指标,有助于临床决策。指导治疗的基本原则是,只要胸腔积液似乎仅靠抗生素治疗就可能进展为明显的脓胸,就需要及时、有效地引流胸腔积液。